BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24715427)

  • 1. A case of CD138-/CD19+/CD4+ IgD plasma cell leukemia.
    Sorigue M; Juncà J; Gassiot S; Millá F; Mate JL; Navarro JT
    Cytometry B Clin Cytom; 2015 Jan; 88(1):69-73. PubMed ID: 24715427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of CD138-/CD19+/CD4+ IgD plasma cell leukemia.
    Sorigue M; Juncà J; Gassiot S; Millá F; Mate JL; Navarro JT
    Cytometry B Clin Cytom; 2014 Mar; ():. PubMed ID: 24659135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells.
    Kim D; Park CY; Medeiros BC; Weissman IL
    Leukemia; 2012 Dec; 26(12):2530-7. PubMed ID: 22733078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
    Kara IO; Sahin B; Paydas S; Cetiner S
    Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma cell leukemia: a retrospective study of 10 cases.
    Agarwal AD; Brahmbhatt BS; Parikh BP; Shah MJ
    Indian J Cancer; 2014; 51(1):18-9. PubMed ID: 24947090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-kit receptor (CD117) expression on plasma cells in monoclonal gammopathies.
    Kraj M; Pogłód R; Kopeć-Szlezak J; Sokołowska U; Woźniak J; Kruk B
    Leuk Lymphoma; 2004 Nov; 45(11):2281-9. PubMed ID: 15512818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric immunophenotypic characteristics of 36 cases of plasma cell leukemia.
    Kraj M; Kopeć-Szlęzak J; Pogłód R; Kruk B
    Leuk Res; 2011 Feb; 35(2):169-76. PubMed ID: 20553988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD138+ carcinocythemia mimicking plasma cell leukemia by flow cytometry.
    Barksdale B; Leith CP
    Blood; 2020 Oct; 136(14):1698. PubMed ID: 33002126
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary plasma cell leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantation.
    Johnson MR; Del Carpio-Jayo D; Lin P; Giralt S; Anderlini P; Champlin RE; Khouri IF; Vadhan-Raj S; Medeiros LJ; Bueso-Ramos CE
    Ann Diagn Pathol; 2006 Oct; 10(5):263-8. PubMed ID: 16979517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cCD79a expression in a case of plasma cell leukemia.
    Alonso ML; Rubiol E; Mateu R; Estivill C; Bellido M; Balmaña J; Nomdedéu JF
    Leuk Res; 1998 Jul; 22(7):649-53. PubMed ID: 9680117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients.
    Hosen N; Matsuoka Y; Kishida S; Nakata J; Mizutani Y; Hasegawa K; Mugitani A; Ichihara H; Aoyama Y; Nishida S; Tsuboi A; Fujiki F; Tatsumi N; Nakajima H; Hino M; Kimura T; Yata K; Abe M; Oka Y; Oji Y; Kumanogoh A; Sugiyama H
    Leukemia; 2012 Sep; 26(9):2135-41. PubMed ID: 22430638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible expression of CD138 on mature follicular B cells is downregulated by IL-4.
    Lee JG; Moon H; Park C; Shin SH; Kang K; Kim TJ
    Immunol Lett; 2013; 156(1-2):38-45. PubMed ID: 24029663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abrupt Development of Plasma Cell Leukemia in a Patient with Chronic Anemia under Follow-up.
    Farzaneh MR; Moradi A; Ravanbod MR; Daghbashi M
    Arch Iran Med; 2016 Jan; 19(1):75-7. PubMed ID: 26702753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma cell leukemia: Clinicopathologic, immunophenotypic and cytogenetic characteristics of 4 cases.
    Alghasham N; Alnounou R; Alzahrani H; Alsharif F
    Hematol Oncol Stem Cell Ther; 2015 Jun; 8(2):71-7. PubMed ID: 25929729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma cell leukemia masquerading as ALL-L3--a case report.
    Tripathy K; Gouda KP; Chakrabarty S; Das AK; Mohanty R
    Indian J Pathol Microbiol; 2005 Apr; 48(2):221-3. PubMed ID: 16758674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Laboratory Characteristics of IgM Primary Plasma Cell Leukemia.
    Wu Y; Zhang X; Ma X; Suo X; Li R
    Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotyping of plasma cells.
    Rawstron AC
    Curr Protoc Cytom; 2006 May; Chapter 6():Unit6.23. PubMed ID: 18770841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple myeloma with CD138 changed from positive to negative: A case report.
    Yu J; Tan L; Wu Q; Rao Y; Ao J; Yang W; Zou B; Chen J
    Cytometry B Clin Cytom; 2021 Mar; 100(2):249-253. PubMed ID: 31967404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of minimal residual disease in multiple myeloma by fluorescent molecular beacons in real time PCR of IgH gene rearrangements and correlation with flow cytometry.
    Kara IO; Duman BB; Afsar CU
    J BUON; 2013; 18(2):442-7. PubMed ID: 23818359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
    Martín P; Santón A; Bellas C
    Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.